GENDER DIFFERENCES IN CARDIAC SYMPTOMS 30 DAYS AFTER PRIMARY PCI FOR ANTERIOR MYOCARDIAL INFARCTION: INSIGHTS FROM INFUSE–AMI  by Sergie, Ziad et al.
E1656
JACC March 12, 2013
Volume 61, Issue 10
TCT@ACC-i2: Invasive and Interventional Cardiology
gender differences in cardiac sympToms 30 days afTer primary pci for anTerior 
myocardial infarcTion: insighTs from infuse-ami
Poster Contributions
Poster Sessions, Expo North
Saturday, March 09, 2013, 10:00 a.m.-10:45 a.m.
Session Title: Coronary Stents
Abstract Category: 47. TCT@ACC-i2: Coronary Intervention, Devices
Presentation Number: 2101-234
Authors: Ziad Sergie, Roxana Mehran, Sorin Brener, Akiko Maehara, Martin Fahy, Uwe Zeymer, Azfar Zaman, Jochen Woehrle, C. Michael Gibson, 
Gregg Stone, Mount Sinai School of Medicine, New York, NY, USA
Background: It is unclear whether gender differences exist in cardiac symptoms after percutaneous coronary intervention (PCI) for ST-segment 
elevation myocardial infarction (STEMI).
methods: The INFUSE-AMI trial randomized patients with anterior STEMI due to proximal or mid left anterior descending occlusion to intracoronary 
abciximab delivered via the ClearWay™ RX catheter vs no abciximab, and to manual thrombus aspiration with the Export® catheter vs no aspiration. 
We compared 30-day infarct size on cardiac magnetic resonance imaging in women and men. We also analyzed the 30-day rates of self-reported 
angina (Canadian Cardiovascular Society; CCS scale) and heart failure (HF; NYHA scale) by gender.
results: Among 452 patients, 118 (26.1%) were female and the average age was 61 years. Women were older than men and more often had 
hypertension, hyperlipidemia, and heart failure. Women experienced a greater delay from symptom onset to hospital arrival (median 137.4 vs 106.8 
min, P<0.0001) and in door-to-device time (median 60 vs 51.6 min, P=0.04) than men. The post-procedure and 30-day outcomes in both groups 
are shown in Table 1.
conclusions: In this trial, women experienced more angina (CCS I) and dyspnea (NYHA I-III) in the first month after primary PCI despite state of 
the art interventions and similar reperfusion success and infarct size. Whether these differences are related to baseline characteristics, disease 
perception or underlying microvascular disease in women deserves further study.
